Benzonatate Capsule
FDA Label NDC 65841-614

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Benzonatate (NDC 65841-614). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 65841-614-01 in bottle of 100 capsules

Benzonatate Capsules USP, 100 mg

Rx only

100 capsules

Benzonatate Capsules (Ae2b2fa5 2b6d 4f86 97a0 28ff5d22e73c 01)

Benzonatate Capsules (Ae2b2fa5 2b6d 4f86 97a0 28ff5d22e73c 01)

NDC 65841-843-01 in bottle of 100 capsules

Benzonatate Capsules USP, 200 mg

Rx only

100 capsules

Benzonatate Capsules (Ae2b2fa5 2b6d 4f86 97a0 28ff5d22e73c 02)

Benzonatate Capsules (Ae2b2fa5 2b6d 4f86 97a0 28ff5d22e73c 02)

* Please review the disclaimer below.